Informatie:
Fout:
ID
18593
Beschrijving
A Randomized, Open-Label Study to Compare the Efficacy and Safety of AT1001 and Enzyme Replacement Therapy (ERT) in Patients With Fabry Disease and AT1001-Responsive GLA Mutations, Who Were Previously Treated With ERT Study Completion
Trefwoorden
Versies (2)
- 02-11-16 02-11-16 -
- 11-11-16 11-11-16 -
Geüploaded op
11 november 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Study Completion Study Galafold (migalastat) AT1001-012 NCT01218659
Study Completion Study Galafold (migalastat) AT1001-012 NCT01218659
Similar models
Study Completion Study Galafold (migalastat) AT1001-012 NCT01218659
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
reference date
Item
Reference date
date
C1719096 (UMLS CUI [1])
Visit
Item
Visit Type
text
C0545082 (UMLS CUI [1])
eCRF
Item
electronic case report form
text
C1516308 (UMLS CUI [1])
Comment
Item
Comment
text
C0947611 (UMLS CUI [1])
Last day on study
Item
Last day on study
date
C2826674 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
CL Item
Yes, all visits through Visit 9/Month 18 (1a)
CL Item
Yes, all visits through Visit 14/Month 30 (1b)
CL Item
No (3)
Item
Has all data for this patient been entered in the EDC system?
integer
C2707520 (UMLS CUI [1])
CL Item
Yes (1)